| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |